D95
Artesunate
Created: | 2018-01-10 |
Last modified: | 2019-01-16 |
Find Related PDB Entry |
---|
Find related ligands: |
---|
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 55 |
Chiral Atom Count | 8 |
Bond Count | 58 |
Aromatic Bond Count | 0 |
Chemical Component Summary | |
---|---|
Name | Artesunate |
Formula | C19 H28 O8 |
Molecular Weight | 384.421 |
Type | NON-POLYMER |
Chemical Descriptors | |||
---|---|---|---|
Type | Program | Version | Descriptor |
SMILES | CACTVS | 3.385 | C[CH]1CC[CH]2[CH](C)[CH](O[CH]3O[C]4(C)CC[CH]1[C]23OO4)OC(=O)CCC(O)=O |
SMILES | OpenEye OEToolkits | 2.0.6 | CC1CCC2C(C(OC3C24C1CCC(O3)(OO4)C)OC(=O)CCC(=O)O)C |
Canonical SMILES | CACTVS | 3.385 | C[C@@H]1CC[C@H]2[C@@H](C)[C@@H](O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4)OC(=O)CCC(O)=O |
Canonical SMILES | OpenEye OEToolkits | 2.0.6 | C[C@@H]1CC[C@H]2[C@H]([C@@H](O[C@H]3[C@@]24[C@H]1CC[C@](O3)(OO4)C)OC(=O)CCC(=O)O)C |
InChI | InChI | 1.03 | InChI=1S/C19H28O8/c1-10-4-5-13-11(2)16(23-15(22)7-6-14(20)21)24-17-19(13)12(10)8-9-18(3,25-17)26-27-19/h10-13,16-17H,4-9H2,1-3H3,(H,20,21)/t10-,11-,12+,13+,16-,17-,18-,19-/m1/s1 |
InChIKey | InChI | 1.03 | FIHJKUPKCHIPAT-AHIGJZGOSA-N |
Drug Info: DrugBank
DrugBank ID | DB09274 |
---|---|
Name | Artesunate |
Groups |
|
Description | Artesunate is indicated for the initial treatment of severe malaria.[L14099] The World Health Organization recommends artesunate as first line treatment for severe malaria.[L890] Artesunate was developed out of a need for a more hydrophilic derivative of [artemisinin].[A203948] Artesunate was granted FDA approval on 26 May 2020.[L14099] |
Synonyms |
|
Brand Names |
|
Indication | Artesunate is indicated for the initial treatment of severe malaria in adult and pediatric patients.[L14099] |
Categories |
|
ATC-Code |
|
CAS number | 88495-63-0 |
Drug Targets
Name | Target Sequence | Pharmacological Action | Actions |
---|---|---|---|
Malaria protein EXP-1 | MKILSVFFLVLFFIIFNKESLAEKTNKETGSGVSSKKKNKKGSGEPLIDV... | unknown | inhibitor |
UDP-glucuronosyltransferase 2B7 | MSVKWTSVILLIQLSFCFSSGNCGKVLVWAAEYSHWMNIKTILDELIQRG... | unknown | substrate |
UDP-glucuronosyltransferase 1A9 | MACTGWTSPLPLCVCLLLTCGFAEAGKLLVVPMDGSHWFTMRSVVEKLIL... | unknown | substrate |
Cytochrome P450 2A6 | MLASGMLLVALLVCLTVMVLMSVWQQRKSKGKLPPGPTPLPFIGNYLQLN... | unknown | substrate |
Albumin | MKWVTFISLLFLFSSAYSRGVFRRDAHKSEVAHRFKDLGEENFKALVLIA... | unknown | binder |
View More |
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
Related Resource References
Resource Name | Reference |
---|---|
PubChem | 6917864 |
ChEMBL | CHEMBL361497 |
ChEBI | CHEBI:63918 |
CCDC/CSD | FAHFAV01, FAHFAV02 |